| EPD115 | COVID-19 disruptions and the adaptation and implementation of a dyad-based intervention to improve antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan: strategies and lessons learned | E-poster | People who inject drugs |
| EPD116 | The perceived impact of social support on HIV-treatment engagement in women who use drugs in Dar es Salaam, Tanzania | E-poster | People who inject drugs |
| EPD117 | Social support as a buffer of negative mental health symptoms during the COVID-19 pandemic among current and former people who inject drugs | E-poster | People who inject drugs |
| EPD118 | Changes in survival of HIV-positive heroin use disorder patients admitted to treatment in Barcelona, Spain: a 30-year multicenter observational study | E-poster | People who inject drugs |
| EPD119 | A roadmap for implementing injectable opioid agonist therapy: learnings from a three-year pilot project | E-poster | People who inject drugs |
| EPD120 | Exploring the relationship between syringe services programs and law enforcement in rural counties in Kentucky (USA) | E-poster | People who inject drugs |
| EPD122 | Influence of descriptive network norms on injection behaviors among people who inject drugs during the COVID-19 pandemic: a latent profile analysis | E-poster | People who inject drugs |
| PESAD24 | Differences in drug use and HIV stigma among people who inject drugs in Kyrgyzstan | Poster exhibition | People who inject drugs |
| EPB172 | Targeted delivery of dolutegravir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPB173 | Characterization of the absorption, metabolism, and excretion of islatravir, an HIV nucleoside reverse transcriptase translocation inhibitor, in humans | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |